logo

Aerie Pharmaceuticals, Inc. (AERI)



Trade AERI now with
  Date
  Headline
9/12/2018 4:01:31 PM Aerie Pharmaceuticals Appoints David Gryska To Board Of Directors
9/11/2018 4:04:17 PM Aerie Pharmaceuticals Appoints Robert Finan As Director Of Finance
9/10/2018 6:30:43 AM Aerie Pharmaceuticals Appoints Thomas Shepard As VP, Implant Manufacturing
8/20/2018 6:31:07 AM Aerie Appoints Jeffrey White As Director, Toxicology And Pharmacokinetics
8/15/2018 6:34:17 AM Aerie Announces Topline Efficacy Results From Study Designed To Evaluate Effect Of Rhopressa
8/1/2018 6:41:16 AM Aerie And DSM Biomedical Expand Collaborative Research, Development, And License Agreement
7/23/2018 6:33:43 AM Aerie Pharma Announces Early Notification Of FDA Acceptance Of NDA Submission For Roclatan
7/16/2018 6:31:16 AM Aerie Pharmaceuticals Announces Appointment Of Randall Brown As Director, Payer Marketing
5/15/2018 6:32:56 AM Aerie Pharmaceuticals Submits NDA To FDA For Roclatan (netarsudil/latanoprost Ophthalmic Solution) 0.02%/0.005%
5/1/2018 6:31:35 AM Aerie Appoints Concetta Perro As Commercial Counsel
4/30/2018 6:32:26 AM Aerie Announces U.S. Launch Of Rhopressa (netarsudil Ophthalmic Solution) 0.02%
4/12/2018 6:35:02 AM Aerie Pharma Announces Appointment Of Scott Laranjo As Director, Marketing, Roclatan
2/20/2018 6:30:40 AM Aerie Pharmaceuticals Appoints John LaRocca As General Counsel
2/12/2018 6:32:14 AM Aerie Pharmaceuticals Appoints Scott Cassady As Regional Sales Director For The Central Region
2/8/2018 6:34:43 AM Aerie Pharma Appoints Brad Fuller As Director Of National Accounts In Its Market Access Department
2/1/2018 6:35:05 AM Aerie Pharmaceuticals Appoints Tad Heitmann As Head Of Communications
1/24/2018 6:31:01 AM Aerie Pharma Announces Pricing Of Public Offering Of Common Stock
1/23/2018 4:06:57 PM Aerie Pharma Announces Public Offering Of Common Stock
1/16/2018 6:31:50 AM Aerie Pharma Names Nils Hauptmann As Director Of Regulatory Affairs And Pharmacovigilance
1/7/2018 9:50:22 AM New Drugs Approved In December